Scarica l'app Stockscreener
27.74
0.00%
0.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$27.74
Aprire:
$27.71
Volume 24 ore:
244.65K
Relative Volume:
0.62
Capitalizzazione di mercato:
$1.27B
Reddito:
$722.68M
Utile/perdita netta:
$134.71M
Rapporto P/E:
10.39
EPS:
2.67
Flusso di cassa netto:
$109.94M
1 W Prestazione:
+4.84%
1M Prestazione:
+8.15%
6M Prestazione:
+23.62%
1 anno Prestazione:
-24.27%
Intervallo 1D:
$27.43
$28.02
Intervallo di 1 settimana:
$26.11
$28.34
Portata 52W:
$20.39
$39.01
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
909-980-9484
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Confronta AMPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
27.74 | 1.27B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
127.17 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.31 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.91 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.01 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
45.79 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Equal Weight |
| 2025-08-12 | Aggiornamento | Needham | Hold → Buy |
| 2025-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Iniziato | Wells Fargo | Equal Weight |
| 2024-03-05 | Iniziato | JP Morgan | Overweight |
| 2023-11-17 | Iniziato | BofA Securities | Neutral |
| 2023-07-25 | Ripresa | Jefferies | Buy |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-07-29 | Iniziato | CapitalOne | Overweight |
| 2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Iniziato | Northland Capital | Outperform |
| 2019-03-13 | Downgrade | Needham | Buy → Hold |
| 2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Reiterato | Needham | Buy |
| 2018-03-13 | Reiterato | Needham | Buy |
| 2017-12-01 | Reiterato | Needham | Buy |
| 2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Reiterato | Needham | Buy |
| 2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Reiterato | Needham | Buy |
| 2016-05-10 | Reiterato | Needham | Buy |
| 2016-02-19 | Iniziato | Wells Fargo | Outperform |
| 2015-06-19 | Reiterato | Needham | Buy |
| 2015-06-03 | Iniziato | Raymond James | Strong Buy |
| 2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
(AMPH) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Amphastar Pharmaceuticals, Inc. $AMPH Stock Holdings Trimmed by CX Institutional - MarketBeat
Why Amphastar Pharmaceuticals Inc. stock remains undervaluedJuly 2025 PostEarnings & Expert-Curated Trade Recommendations - ulpravda.ru
Assessing Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Momentum - Sahm
Will Amphastar Pharmaceuticals Inc. stock benefit from AI adoption2025 Support & Resistance & Fast Entry High Yield Stock Tips - ulpravda.ru
Is Amphastar Pharmaceuticals Inc. stock affected by interest rate hikesWeekly Profit Report & High Return Trade Opportunity Guides - ulpravda.ru
Is Amphastar Pharmaceuticals Inc. stock a smart buy before Fed meetingExit Point & Daily Profit Focused Screening - ulpravda.ru
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference - ACCESS Newswire
Amphastar Expands BAQSIMI® Distribution in Asia - MSN
Value Recap: Is Amphastar Pharmaceuticals Inc stock trading near support levels2025 Technical Patterns & Weekly Breakout Watchlists - moha.gov.vn
Amphastar Pharmaceuticals, Inc. $AMPH Shares Sold by Pacer Advisors Inc. - MarketBeat
What analysts say about Amphastar Pharmaceuticals Inc stockTake Profit Strategies & Outstanding Investment Portfolio - earlytimes.in
Amphastar Director Sells 16,679 Shares for $441,800 - AOL.com
Amphastar Pharmaceuticals Inc Stock Analysis and ForecastVolatility Index Analysis & Swing Trade Smarter With Data Insights - earlytimes.in
Will Amphastar Pharmaceuticals Inc. stock split again soonStock Screening Results & Make Confident Moves With Forecasting Models - bollywoodhelpline.com
Is Amphastar Pharmaceuticals Inc stock affected by interest rate hikesShort Setup & Reliable Intraday Trade Alerts - moha.gov.vn
How supply chain issues affect Amphastar Pharmaceuticals Inc. stockInstitutional Holding Changes & Minimal Investment Portfolio - bollywoodhelpline.com
Responsive Playbooks and the AMPH Inflection - Stock Traders Daily
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
129,339 Shares in Amphastar Pharmaceuticals, Inc. $AMPH Purchased by Rice Hall James & Associates LLC - MarketBeat
Squarepoint Ops LLC Lowers Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
How Investors Are Reacting To Amphastar Pharmaceuticals (AMPH) Teriparatide Pen Approval And Insider Stock Sale - Sahm
Amphastar Pharmaceuticals’ Resilient Q3 2025 Earnings Call - MSN
A Fresh Look at Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Stabilisation - Sahm
Will Amphastar Pharmaceuticals Inc. stock outperform international peersJuly 2025 Review & Community Trade Idea Sharing Platform - Улправда
Can Amphastar’s Recent Rebound Signal a Compelling Opportunity in 2025? - Sahm
Is Amphastar Pharmaceuticals Inc. (29A) stock dividend growth reliable2025 AllTime Highs & High Conviction Buy Zone Alerts - Улправда
Why Amphastar Pharmaceuticals Inc. (29A) stock could be top winnerJuly 2025 Price Swings & Weekly Stock Breakout Alerts - Улправда
Why retail investors favor Amphastar Pharmaceuticals Inc. stockTreasury Yields & Daily Entry Point Trade Alerts - Улправда
How strong is Amphastar Pharmaceuticals Inc. stock revenue growthEarnings Performance Report & Free Verified High Yield Trade Plans - Улправда
Is Amphastar Pharmaceuticals Inc. stock a buy for dividend growthJuly 2025 Chart Watch & AI Based Buy/Sell Signal Reports - DonanımHaber
Geopolitics Watch: Will Amphastar Pharmaceuticals Inc. stock outperform international peersJuly 2025 Closing Moves & Weekly Market Pulse Updates - Улправда
Growth Review: Is Amphastar Pharmaceuticals Inc. (29A) stock dividend growth reliable2025 Volatility Report & Weekly Watchlist for Consistent Profits - Улправда
Insider Selling: Amphastar Pharmaceuticals (NASDAQ:AMPH) EVP Sells 9,787 Shares of Stock - MarketBeat
Risk Analysis: Why retail investors favor Amphastar Pharmaceuticals Inc. stockTrade Exit Report & Reliable Breakout Forecasts - Улправда
Will Amphastar Pharmaceuticals Inc. (29A) stock beat value stocksJuly 2025 Sector Moves & Free Fast Entry Momentum Trade Alerts - Улправда
Amphastar Pharmaceuticals Insider Sold Shares Worth $256,379, According to a Recent SEC Filing - marketscreener.com
Amphastar Pharmaceuticals Senior EVP Zhou Rong Sells Shares - TradingView — Track All Markets
Amphastar Pharmaceuticals (AMPH) executive logs option exercise and 9,787-share sale - Stock Titan
Rate Cut: Can Amphastar Pharmaceuticals Inc. stock withstand economic slowdownMarket Performance Summary & Stepwise Swing Trade Plans - Улправда
Amphastar reports FDA approval for teriparatide injection - MSN
Will FDA Approval of an In‑House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative? - Yahoo Finance
Amphastar: Baqsimi Props Up Flat Growth, But 2026 Guidance Looks Fragile (NASDAQ:AMPH) - Seeking Alpha
Is FDA‑Cleared U.S.‑Made Teriparatide Pen Altering The Investment Case For Amphastar Pharmaceuticals (AMPH)? - simplywall.st
Amphastar Pharmaceuticals Director Makes Noteworthy Stock Sale - TipRanks
Insider Selling: Floyd Petersen Sells Shares of Amphastar Pharma - GuruFocus
Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Sells $44,623.53 in Stock - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Sells $62,881.92 in Stock - MarketBeat
Amphastar Pharmaceuticals Director Sells Over 4,000 Shares - TradingView — Track All Markets
Dir Petersen Sells 4,163 ($107.5K) Of Amphastar Pharmaceuticals Inc [AMPH] - TradingView — Track All Markets
Amphastar Pharmaceuticals (AMPH) director discloses recent common stock sales - Stock Titan
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.37%
1.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):